Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-24T03:49:42.113Z Has data issue: false hasContentIssue false
  • English
  • Français

Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms

Published online by Cambridge University Press:  05 March 2007

Elizabeth A. Williams ,
Jonathan M. Coxhead  and
John C. Mathers
Elizabeth A. Williams*
Affiliation:
Human Nutrition Research Centre, School of Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, NE1 7RU, UK
Jonathan M. Coxhead
Affiliation:
Human Nutrition Research Centre, School of Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, NE1 7RU, UK
John C. Mathers
Affiliation:
Human Nutrition Research Centre, School of Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, NE1 7RU, UK
*
*Corresponding author: DrLizWilliams, fax +44 191 222 8684, [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Epidemiological evidence suggests that a high intake of resistant starch and NSP protects against colo-rectal cancer. The mechanisms underlying this protection are thought to be mediated by the short-chain fatty acid butyrate, which is present in the colonic lumen in millimolar concentrations as a result of bacterial fermentation of carbohydrates that have resisted digestion in the small intestine. In vitro studies have shown that butyrate displays a host of chemo-preventative properties including increased apoptosis, reduced proliferation, down regulation of angiogenesis, enhanced immunosurveillance and anti-inflammatory effects in colo-rectal cancer cell lines. However, the molecular mechanisms underlying the apparent chemo-preventative actions of butyrate are largely unknown. The evidence supporting the role of butyrate as an anti-cancer agent is reviewed, with particular emphasis on those studies that have attempted to elucidate the mechanism of action of butyrate. Our understanding of the mechanistic action of butyrate and its role in cancer prevention is likely to advance considerably in this post-genomic era with the application of genomic and proteomic technologies. Studies are described that have used gene array and proteomic techniques to investigate the response of colo-rectal cancer cells to butyrate. These pioneering studies illustrate the potential of these technologies to help characterise the molecular responses of the cancer cell to butyrate, and to define the role of butyrate (and other nutrients) in the prevention of colo-rectal cancer.

Keywords

ButyrateMicro-array techniquesColo-rectal cancer
Type
Session: Short-chain fatty acids
Information
Proceedings of the Nutrition Society , Volume 62 , Issue 1 , February 2003 , pp. 107 - 115
Copyright
Copyright © The Nutrition Society 2003

References

Anderson, L, Seilhamer, J (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18, 533–537.CrossRefGoogle ScholarPubMed
Andoh, A, Shimada, M, Araki, Y, Fujiyama, Y, Bamba, T (2002) Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells. Cancer Immunology and Immunotherapy 50, 663–672.Google ScholarPubMed
Armstrong, F, Mathers, JC (2000) Kill and cure: dietary augmentation of immune defences against colon cancer. Proceedings of the Nutrition Society 59, 215–220.CrossRefGoogle ScholarPubMed
Ballestar, E, Esteller, M (2002) The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis 23, 1103–1109.CrossRefGoogle ScholarPubMed
Bingham, SA (1990) Mechanisms and experimental and epidemiological evidence relating dietary fibre (non-starch polysaccharides) and starch to protection against large bowel cancer. Proceedings of the Nutrition Society 49, 153–171.CrossRefGoogle ScholarPubMed
Blackstock, WP, Weir, MP (1999) Proteomics: quantitative and physical mapping of cellular proteins. Trends in Biotechnology 17, 121–127.CrossRefGoogle ScholarPubMed
Blagosklonny, MV, Wu, GS, Omura, S, el-Deiry, WS (1996) Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochemical and Biophysical Research Communications 227, 564–569.CrossRefGoogle ScholarPubMed
Bonnotte, B, Favre, N, Reveneau, S, Micheau, O, Droin, N, Garrido, C, Fontana, A, Chauffert, B, Solary, E, Martin, F (1998) Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death and Differentiation 5, 480–487.CrossRefGoogle ScholarPubMed
Browne, SJ, Macfarlane, M, Cohen, GM, Paraskeva, C (1998) The adenomatous polyposis coli protein and retinoblastoma proteins are cleaved early in apoptosis and are potential substrates for caspases. Cell Death and Differentiation 5, 206–213.CrossRefGoogle ScholarPubMed
Browne, SJ, Williams, AC, Hague, A, Butt, AJ, Paraskeva, C (1994) Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. International Journal of Cancer 59, 56–64.CrossRefGoogle ScholarPubMed
Butt, AJ, Hague, A, Paraskeva, C (1997) Butyrate- but not TGFβ 1 - induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase. Cell Death and Differentiation 4, 725–734.CrossRefGoogle ScholarPubMed
Chai, F, Evdokiou, A, Young, GP, Zalewski, PD (2000) Involvement of p21 Waf1/Cip1 and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate. Carcinogenesis 21, 7–14.CrossRefGoogle ScholarPubMed
Clarke, KO, Feinman, R, Harrison, LE (2001) Tributyrin, an oral butyrate analogue, induces apoptosis through activation of caspase-3. Cancer Letters 171, 57–65.CrossRefGoogle ScholarPubMed
Cummings, JH, Pomare, EW, Branch, WJ, Naylor, CP, Macfarlane, GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227.CrossRefGoogle ScholarPubMed
D'Anna, JA, Tobey, RA, Gurley, LR (1980) Concentrationdependent effects of sodium butyrate in Chinese hamster cells: cell cycle progression, inner-histone acetylation, histone H1 dephosphorylation, and induction of an H1-like protein. Biochemistry 19, 2656–2671.CrossRefGoogle ScholarPubMed
D'Argenio, G, Cosenza, V, Delle, Cave, M, Iovino, P, Della, Valle, N, Lombardi, G, Mazzacca, G (1996) Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology 110, 1727–1734.CrossRefGoogle ScholarPubMed
Della, Ragione, F, Criniti, V, Della, Pietra, V, Borriello, A, Oliva, A, Indaco, S, Yamamoto, T, Zappia, V (2001) Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Letters 499, 199–204.CrossRefGoogle Scholar
Diakos, C, Prieschl, EE, Saemann, M, Novotny, V, Bohmig, G, Csonga, R, Baumruker, T, Zlabinger, GJ (2002) Novel mode of interference with nuclear factor of activated T-cells regulation in T-cells by the bacterial metabolite n -butyrate. Journal of Biological Chemistry 277, 24243–24251.CrossRefGoogle ScholarPubMed
Duggan, DJ, Bittner, M, Chen, Y, Meltzer, P, Trent, JM (1999) Expression profiling using cDNA microarrays. Nature Genetics 21, 10–14.CrossRefGoogle ScholarPubMed
Evan, G, Littlewood, T (1998) A matter of life and cell death. Science 281, 1317–1322.CrossRefGoogle ScholarPubMed
Faust, D, Hormann, S, Friedrich-Sander, M, Milovic, V, Stein, J (2001) Butyrate and the cytokine-induced alpha1-proteinase inhibitor release in intestinal epithelial cells. European Journal of Clinical Investigation 31, 1060–1063.CrossRefGoogle ScholarPubMed
Gamet, L, Daviaud, D, Denis-Pouxviel, C, Remesy, C, Murat, JC (1992) Effects of short-chain fatty acids on growth and differentiation on the human colon-cancer cell line HT–29. International Journal of Cancer 52, 286–289.CrossRefGoogle Scholar
Giermasz, A, Makowski, M, Nowis, D, Jalili, A, Maj, M, Dabrowsks, A, Czajka, A, Jakobisiak, M, Golab, J (2002) Potentiated antitumour effects of butyrate and actinomycin D in melanoma model in mice. Oncology Reports 9, 199–203.Google Scholar
Hacia, JG, Collins, FS (1999) Mutational analysis using oligonucleotide microarrays. Journal of Medical Genetics 36, 730–736.CrossRefGoogle ScholarPubMed
Hague, A, Manning, AM, Hanlon, KA, Huschtscha, LI, Hart, D, Paraskeva, C (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. International Journal of Cancer 55, 498–505.CrossRefGoogle Scholar
Hanahan, D, Weinberg, RA (2000) The hallmarks of cancer. Cell 100, 57–70.CrossRefGoogle ScholarPubMed
Heerdt, BG, Houston, MA, Augenlicht, LH (1994) Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Research 54, 3288–3294.Google ScholarPubMed
Iacomino, G, Tecce, M, Grimaldi, C, Tosto, M, Russo, GL (2001) Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. Biochemical and Biophysical Research Communications 285, 1280–1289.CrossRefGoogle ScholarPubMed
Inan, MS, Rasoulpour, RJ, Yin, L, Hubbard, AK, Rosenberg, DW, Giardina, C (2000) The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line. Gastroenterology 118, 724–734.CrossRefGoogle Scholar
Jones, MB, Krutzsch, H, Shu, H, Zhao, Y, Liotta, LA, Kohn, EC, Petricoin, EF (2002) Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2, 76–84.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Jordan, NJ, Kolios, G, Abbot, SE, Sinai, MA, Thompson, DA, Petraki, K, Westwick, J (1999) Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. Journal of Clinical Investigation 104, 1061–1069.CrossRefGoogle ScholarPubMed
Kiess, M, Gill, RM, Hamel, PA (1995) Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubules. Oncogene 10, 159–166.Google Scholar
Kitahara, O, Furukawa, Y, Tanaka, T, Kilhara, C, Ono, K, Yanagawa, R, Nita, ME, Takagi, T, Nakamura, Y, Tsunoda, T (2001) Alterations of gene expression during colorectal carcinogenesis Short-chain fatty acids 115 revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia. Cancer Research 61, 3544–3549.Google Scholar
Klose, J (1999) Large-gel 2-D electrophoresis. Methods in Molecular Biology 112, 147–172.Google Scholar
Kruh, J (1982) Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Molecular and Cellular Biochemistry 42, 65–82.Google ScholarPubMed
Kruh, J, Defer, N, Tichonicky, L (1995) Effects of butyrate on cell proliferation and gene expression. In Physiological and Clinical Aspects of Short-chain Fatty Acids, pp.275–288 [Cummings, JH, Rombeau, JL, Sakata, T, editors] Cambridge: Cambridge University Press.Google Scholar
Leder, A, Leder, P (1975) Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5, 319–322.CrossRefGoogle ScholarPubMed
Liu, Y, Kulesz-Martin, M (2001) p53 protein at the hub of cellular DNA damage response pathways through sequence-specific and non-sequence-specific DNA binding. Carcinogenesis 22, 851–860.CrossRefGoogle ScholarPubMed
Luo, J, Duggan, DJ, Chen, Y, Sauvageot, J, Ewing, CM, Bittner, ML, Trent, JM, Isaacs, WB (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Research 61, 4683–4688.Google ScholarPubMed
Mahyar-Roemer, M, Roemer, K (2001) p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20, 3387–3398.CrossRefGoogle ScholarPubMed
Mariadason, J, Corner, GA, Augenlicht, LH (2000) Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: Comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colorectal cancer. Cancer Research 60, 4561–4572.Google Scholar
Mohr, S, Leikauf, GD, Keith, G, Rihn, BH (2002) Microarrays as cancer keys: an array of possibilities. Journal of Clinical Oncology 20, 3165–3175.CrossRefGoogle ScholarPubMed
Nancey, S, Bienvenu, J, Coffin, B, Andre, F, Decos, L, Flourie, B (2002) Butyrate strongly inhibits in vitro stimulated release of cytokines in blood. Digestive Diseases and Sciences 47, 921–928.CrossRefGoogle ScholarPubMed
O'Farrell, PH (1975) High resolution two-dimensional electrophoresis of proteins. Journal of Biological Chemistry 250, 4007–4021.CrossRefGoogle ScholarPubMed
Pellizzaro, C, Coradini, D, Daidone, GG (2002) Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis 23, 735–740.CrossRefGoogle ScholarPubMed
Perrin, P, Cassagnau, E, Burg, C, Party, Y, Vavasseur, F, Harb, J, Le Pendu, J, Douillard, J-Y, Galmiche, J-P, Bornet, F, Meflah, K (1994) An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis. Gastroenterology 107, 1397–1408.CrossRefGoogle ScholarPubMed
Prasad, KN, Sinha, PK (1976) Effect of sodium butyrate on mammalian cells in culture. In Vitro 12, 125–132.CrossRefGoogle ScholarPubMed
Ruemmele, FM, Dionne, S, Qureshi, I, Sarma, DSR, Levy, E, Seidman, EG (1999) Butyrate mediates Caco–2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase–3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death and Differentiation 6, 729–735.CrossRefGoogle ScholarPubMed
Saemann, MD, Bohmig, GA, Osterreicher, CH, Burtscher, H, Parolini, O, Diakos, C, Stockl, J, Horl, WH, Zlabinger, GJ (2000) Antiinflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB Journal 14, 2380–2382.CrossRefGoogle ScholarPubMed
Saemann, MD, Parolini, O, Bohmig, GA, Kelemen, P, Krieger, PM, Neumuller, J, Kanrr, K, Kammlaander, W, Horl, WH, Diakos, C, Stuhlmeier, K, Zlabinger, GJ (2002) Bacterial metabolite interference with maturation of human monocyte-derived dendritic cells. Journal of Leukocyte Biology 71, 238–246.CrossRefGoogle ScholarPubMed
Sapolsky, RJ, Hsie, L, Berno, A, Ghandour, G, Mittmann, M, Fan, JB (1999) High-throughput polymorphism screening and genotyping with high-density oligonucleotide arrays. Genetic Analysis 14, 187–192.CrossRefGoogle ScholarPubMed
Schwartz, B, Avivi-Green, C, Polak-Charcon, S (1998) Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cell. Molecular and Cellular Biochemistry 188, 21–30.CrossRefGoogle Scholar
Siavoshian, S, Blottière, HM, Le Foll, E, Kaeffer, B, Cherbut, C, Galmiche, JP (1997) Comparison of the effect of different short chain fatty acids on the growth and differentiation of human colonic carcinoma cell lines in vitro. Cell Biology International 21, 281–287.CrossRefGoogle ScholarPubMed
Siavoshian, S, Segain, J-P, Kornprobst, M, Bonnet, C, Cherbut, C, Galmiche, J-P, Blottière, HM (2000) Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46, 507–514.CrossRefGoogle ScholarPubMed
Southern, E, Mir, K, Shchepinov, M (1999) Molecular interactions on microarrays. Nature Genetics 21, 5–9.CrossRefGoogle ScholarPubMed
Steinbach, G, Lynch, PM, Phillips, RK, Wallace, MH, Hawk, E, Gordon, GB, Wakabayashi, N, Saunders, B, Shen, Y, Fujimura, T, Su, LK, Levin, B (2000) The effect of celecoxib, a cyclooxygenase –2 inhibitor, in familial adenomatous polyposis. New England Journal of Medicine 342, 1946–1952.CrossRefGoogle ScholarPubMed
Steinman, RA, Hoffman, B, Iro, A, Guillouf, C, Libermann, DA, el-Houseini, ME (1994) Induction of p21 (WAF–1/CIP1) during differentiation. Oncogene 9, 3389–3396.Google ScholarPubMed
Tan, S, Seow, TK, Liang, RC, Koh, S, Lee, C, Chung, M, Hooi, S (2002) Proteome analysis of butyrate-treated human colon cancer cells (HT29). International Journal of Cancer 98, 523–531.CrossRefGoogle Scholar
Van Eyk, JE (2001) Proteomics: unraveling the complexity of heart disease and striving to change cardiology. Current Opinion in Molecular Therapeutics 3, 546–553.Google ScholarPubMed
Wasinger, VC, Cordwell, SJ, Cerpa-Poljak, A, Yan, JX, Gooley, AA, Wilkins, MR, Duncan, MW, Harris, R, Williams, KL, Humphery-Smith, I (1995) Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16, 1090–1094.CrossRefGoogle ScholarPubMed
Webb, SJ, Nicholson, D, Bubb, VJ, Wyllie, AH (1999) Caspasemediated cleavage of APC results in an amino-terminal fragment with an intact armadillo repeat domain. FASEB Journal 13, 339–346.CrossRefGoogle Scholar
Weinberg, RA (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323–330.CrossRefGoogle ScholarPubMed
Whitehead, RH, Young, GP, Bhathal, PS (1986) Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM 1215). Gut 27, 1457–1463.CrossRefGoogle Scholar
Wintersberger, E, Mudrak, I, Wintersberger, U (1983) Butyrate inhibits mouse fibroblasts at a control point in the G1 phase. Journal of Cellular Biochemistry 21, 239–247.CrossRefGoogle Scholar
World Cancer Research Fund and the American Institute of Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, DC: World Cancer Research Fund and the American Institute of Cancer Research.Google Scholar